...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19

Wonderful, absolutely Wonderful!!!   Will not take many days to enroll 100 patients. 

Do we need a P3 (larger group) after this?

Question to our knowledgeable followers, how many days after the four weeks will they know the effect of ABL and what parts of the body, heart, lungs, kidneys showed improvement?

Seems, in four weeks either the patient gets better or not.  

Interesting, i recall in the early 12 or 13 week studies, ABL needed about 5 to 6 weeks to begin HDL production.  There are so many benefits with ABL.  Hope this study opens the doors.  We have longed to see this.

Thank you Canada!  sidebar

Share
New Message
Please login to post a reply